Product
tinlarebant
1 clinical trial
1 indication
Indication
Stargardt DiseaseClinical trial
Phase 1/2, Open-Label, Dose-Finding Followed by 2-Year Extension Study to Evaluate Safety and Tolerability of Tinlarebant in Adolescent Subjects With Stargardt DiseaseStatus: Completed, Estimated PCD: 2023-08-15